New pill tested for Tough-to-Treat blood cancer
NCT ID NCT06351644
Summary
This study tested a new oral drug called Narazaciclib, given with a steroid (dexamethasone), for people with multiple myeloma that has come back or stopped responding to standard treatments. The main goals were to find a safe dose and see if the combination could help control the cancer. The trial was for adults whose myeloma had progressed after at least two prior lines of therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mount Sinai Health System
New York, New York, 10029, United States
Conditions
Explore the condition pages connected to this study.